Abstract |
The intracerebroventricular (i.c.v.) injection of (-)- isoprenaline and the selective beta 1-adrenoceptor agonist, RO363, elicited reproducible dose-related increases in heart rate in unanaesthetized and anaesthetized rabbits. (-)- Isoprenaline produced vasodepressor effects in unanaesthetized animals, whereas both catecholamines decreased blood pressure in anaesthetized rabbits. Pretreatment with guanethidine sulphate (5 mg/kg i.v.) reduced but did not abolish the tachycardia elicited by i.c.v. RO363, whereas heart rate responses to i.c.v. (-)- isoprenaline were unaffected. Pretreatment of anaesthetized rabbits with hexamethonium bromide (10 mg/kg i.v.) did not markedly affect the tachycardia elicited by i.c.v. RO363 and reduced the response to i.c.v. (-)- isoprenaline in only one out of five experiments. The results suggest that there is a marked leakage of centrally administered catecholamines into the peripheral circulation and that the rabbit may be unsuited for examining centrally mediated cardiovascular effects of catecholamines.
|
Authors | C Maccarrone, E Malta, C Raper |
Journal | Clinical and experimental pharmacology & physiology
(Clin Exp Pharmacol Physiol)
1983 Jul-Aug
Vol. 10
Issue 4
Pg. 421-5
ISSN: 0305-1870 [Print] Australia |
PMID | 6138175
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Adrenergic beta-Agonists
- Catecholamines
- Catechols
- Hexamethonium Compounds
- Propanolamines
- Hexamethonium
- Ro 363
- Isoproterenol
- Guanethidine
|
Topics |
- Adrenergic beta-Agonists
(pharmacology)
- Animals
- Catecholamines
(cerebrospinal fluid)
- Catechols
- Guanethidine
(pharmacology)
- Hexamethonium
- Hexamethonium Compounds
(pharmacology)
- Injections, Intraventricular
- Isoproterenol
(administration & dosage, pharmacology)
- Propanolamines
(administration & dosage, pharmacology)
- Rabbits
|